ABSTRACT
INTRODUCTION
The exercise electrocardiogram (ECG) is a well-validated procedure for establishing the diagnosis of obstructive coronary heart disease (CAD).
1 One of the most identifiable ECG signs of myocardial ischemia during exercise testing is an ST-segment change. T-wave inversion can be seen on ECG in acute coronary syndrome or unstable angina and myocardial infarction. 2, 3 For patients who cannot exercise adequately, pharmacologic myocardial perfusion imaging (MPI) using adenosine, dipyridamole, and regadenoson is used widely as a diagnostic tool for detecting obstructive CAD. 4, 5 The interpretation of these studies depends primarily on the imaging results because the sensitivity of ECG in this setting is poor. 5, 6 Adenosine-induced STsegment depression is a highly specific marker for obstructive CAD. However, other ECG changes during pharmacologic stress testing have not been well described in predicting CAD. 7 Specifically, the significance of T-wave inversion in multiple ECG leads without STsegment depression during regadenoson injection was described in a series of patients with normal MPI.
METHODS
ECGs were reviewed retrospectively in 64 consecutive patients who had regadenoson MPI and coronary angiography for evaluation of CAD from June 1, 2016 to August 31, 2018. Five cases were identified with new, isolated T-wave inversion in multiple ECG leads with regadenoson injection.
RESULTS
The clinical characteristics, ECG, and coronary angiographic findings of these five cases are summarized in Tables 1 and 2 . Despite normal MPI in these patients, coronary angiography was performed because their clinical presentations were highly suggestive of significant CAD. The ECGs before and after regadenoson injection in cases one, two, and three are shown in Figure 1 . At coronary angiography, three of the five cases showed obstructive coronary artery disease, three underwent percutaneous intervention, and case five had nonobstructive CAD as determined by fractional flow reserve (FFR) method. 
DISCUSSION
The electrophysiologic consequences of myocardial ischemia are responsible for the typical ST-T wave abnormalities seen on the ECG. 9 The ST-segment coincides with the plateau or phase two of ventricular repolarization, and the T-wave reflects the time sequence of phase three repolarization. The action potentials become markedly altered during localized myocardial ischemia with exercise testing resulting in ST-T changes. There are multiple causes of T-wave inversion and they are well described in the literature. 10 In patients with unstable angina, T-wave inversion in the precordial leads have been reported since 1982 as narrow, sharp, and symmetrical waves reflecting high grade stenosis of proximal LAD. 11 The ST-segment depression and/ or elevation during pharmacologic stress MPI were associated with severe CAD or future cardiac event. 12, 13 Regadenoson is a selective A2a receptor agonist that causes coronary vasodilatation through the production of cyclic adenosine monophosphate, stimulation of potassium channels, and decreased intracellular calcium uptake. 14 The effects of regadenoson on ST-segment was studied by Zahid et al. 7 ST-segment depression was seen in 15.7% of patients, however, the sensitivity of the finding for predicting ischemia on the nuclear images was low (7.0%), therefore, it was thought of little clinical value. The effects of regadenoson on T-wave has not been reported to our knowledge.
In all our cases, new, isolated T-wave inversion were observed in multiple ECG leads after regadenoson injection without ST-segment depression. All cases had nonspecific ST-T changes on their baseline ECGs and normal MPI. At coronary angiography, three of five had obstructive CAD. The exact mechanism for this diffuse, new T-wave inversion without ST-segment changes after regadenoson infusion is not known. It may represent transient but diffuse micro-vascular ischemia induced by regadenoson as the location of T-wave changes on ECG are not corresponding to the anatomical location(s) of severe coronary artery stenosis detected by coronary angiography in cases three and four. Thus, the transient and diffuse micro-vascular ischemia after regadenoson injection might blunt its vasodilatory effects on epicardial coronaries leading to false negative results of MPI in those patients with severe CAD. Further studies are necessary to elucidate the exact mechanisms of these ECG changes with regadenoson injection.
In conclusion, our case series showed for the first time that new, isolated T-wave inversion in multiple ECG leads with regadenoson injection were observed in our patients with normal MPI. These ECG findings may be associated with false negative MPI as three of them had obstructive CAD, but future, larger studies are needed for definitive conclusions regarding these ECG findings. At this time, careful observation and scrutiny of all ECG changes, especially new, isolated T-wave inversion in multiple leads with regadenoson injection during pharmacological MPI is advisable to identify potential obstructive CAD despite normal MPI findings.
